Faculty profile

Michael Heffernan

Back to faculty
Assistant Clinical Professor (Adjunct)MedicineMcMaster University

Research

Research areas, by share of publications

Research areas are derived from OpenAlex topics of their publications.

39 publications.

01

ADHERENCE AND PERSISTENCE WITH VUTRISIRAN, AN RNAI THERAPEUTIC FOR THE TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS

Heffernan ML, Patel A, Kauf T

Journal of the American College of Cardiology2026First author
02

Low-Density Lipoprotein Cholesterol Reduction with Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies in Women: A Systematic Review

Buttenham OK, Vethanayagam R, Triemstra SL, Heffernan M

CJC Open2026Senior author
03

Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial

Rivard L, Khairy P, Talajic M, Tardif J-C, Healey JS, Black SE, Andrade JG, Field TS, Nault I, Bherer L

Nature Medicine2026
04

The Intersection of Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Recent Insights in a Challenging Area

Heffernan M, Rutherford S

CJC Open202513 citationsFirst author
05

P250 CHARACTERIZING LIPOPROTEIN(A) TESTING AND CONCENTRATIONS IN CANADIANS WITH CARDIOVASCULAR DISEASE: BASELINE RESULTS FROM THE LIPOPROTEIN(A) AWARENESS PROGRAM

Iatan I, Leiter L, Thanassoulis G, Heffernan M, Tanfous M, Chamoun C, Druce I, Goldin L, Tan M, Langer A

Canadian Journal of Cardiology2025
06

Guideline Directed Anticoagulant Treatment and Dosing in a Contemporary Atrial Fibrillation Cohort: Analysis of the TRANSECT-AF Program

Clifford C, Goodman SG, Tan MK, Gregoire J, Habert J, Gupta A, Chow W, Jaffer S, Aggarwal SG, Heffernan M

CJC Open2025Senior author
07

Contemporary use of guideline‐based higher potency P2Y12 receptor inhibitor therapy in patients with moderate‐to‐high risk non‐ST‐segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross‐sectional study

Patel A, Goodman SG, Tan M, Suskin N, McKelvie R, Mathew AL, Lutchmedial S, Dehghani P, Lavoie AJ, Huynh T

Clinical Cardiology20215 citations
08

Life and limb protection with dual anti-thrombotic pathway inhibition: COMPASS ushers in a new day in atherothrombotic risk reduction

Verma S, Eikelboom JW, Al-Omran M, Choi R, Heffernan M, Teoh H, Bhatt DL

Med20214 citations
09

Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II Study

Arbel Y, Patel AD, Goodman SG, Tan MK, Suskin N, McKelvie RS, Mathew AL, Ahmed F, Lutchmedial S, Dehghani P

CJC Open20211 citations
10

Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure

Van Spall HGC, Lee SF, Xie F, Oz UE, Perez R, Mitoff PR, Maingi M, Tjandrawidjaja MC, Heffernan M, Zia MI

Journal of the American Medical Association (JAMA)2019258 citationsOpen Access
Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for
Subject: Prospective PhD student: Acute Myocardial Infarction Research Dear Professor Heffernan, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "ADHERENCE AND PERSISTENCE WITH VUTRISIRAN, AN RNAI THERAPEUTIC FOR THE TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]
Open in email
Something wrong or missing on this profile? Suggest a correction